# Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

> **NCT00310050** · PHASE1 · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 4 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** pemetrexed disodium
- **DEVICE:** Radiotherapy

## Key facts

- **NCT ID:** NCT00310050
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2018-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00310050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00310050, "Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00310050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*